- Home
- HURA vs VERI Comparison
HURA vs VERI Comparison
Compare HURA & VERI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HURA | VERI |
|---|---|---|
| Founded | 2009 | 2014 |
| Country | United States | United States |
| Employees | 22 | N/A |
| Industry | | EDP Services |
| Sector | | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 160.5M | 142.2M |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | HURA | VERI |
|---|---|---|
| Price | $2.34 | $1.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 5 |
| Target Price | ★ $9.50 | $7.00 |
| AVG Volume (30 Days) | 718.2K | ★ 2.8M |
| Earning Date | 05-15-2026 | 04-15-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $92,637,000.00 |
| Revenue This Year | N/A | $52.20 |
| Revenue Next Year | N/A | $3.06 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $1.16 |
| 52 Week High | $3.90 | $9.42 |
Technical Indicators
Market Signals| Indicator | HURA | VERI |
|---|---|---|
| Relative Strength Index (RSI) | 50.51 | 33.98 |
| Support Level | $2.09 | N/A |
| Resistance Level | $2.71 | $1.54 |
| Average True Range (ATR) | 0.22 | 0.12 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 36.43 | 13.16 |
Price Performance
Historical ComparisonAbout HURA TuHURA Biosciences Inc.
TuHURA Biosciences Inc is a phase 3 clinical stage immuno-oncology company with three distinct technologies focused on the development of novel therapeutics designed to overcome primary and acquired resistance to cancer immunotherapies. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. The company operates in one reportable segment, which includes all activities related to advancing therapies for cancer treatment.
About VERI Veritone Inc.
Veritone Inc is a provider of artificial intelligence (AI) computing solutions and services. It generates revenue through the delivery of its Software Products and Services which consists of revenues generated from Commercial Enterprise and Government and Regulated Industries customers using the company's aiWARE platform and hiring solutions, any related support and maintenance services, and any related professional services associated with the deployment and/or implementation of such solutions, Managed Services which consist of revenues generated from Commercial Enterprise customers using company's content licensing services, advertising agency, influencer management and related services. It has presence in the United States, the United Kingdom, France, Australia, Israel, and India.